March 15, 2016 / 11:43 AM / a year ago

BRIEF-M Pharmaceutical Mathew Lehman resigns as President and CEO

1 Min Read

March 15 (Reuters) - M Pharmaceutical Inc

* Mathew Lehman has resigned from board of directors and from his position as President and CEO

* Company is undertaking a search for a new CEO

* Previously announced letter of intent to acquire reformulated Orlistat from Chelatexx, LLC allowed to lapse by parties Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below